We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current INO market cap is 49.69M. The company's latest EPS is USD -2.9245 and P/E is -0.46.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 101k | 0 | 117k | 65k |
| Operating Income | -31.61M | -33.53M | -27.02M | -21.4M | -24.36M |
| Net Income | -30.47M | -32.24M | -25.17M | -19.38M | -19.7M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 7.41M | 1.78M | 10.26M | 832k | 218k |
| Operating Income | -87.53M | -301.77M | -269.47M | -143.17M | -113.56M |
| Net Income | -166.41M | -303.66M | -279.82M | -135.12M | -107.25M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 129.11M | 133.8M | 107.06M | 113.2M | 87.27M |
| Total Liabilities | 34.67M | 37.06M | 33.52M | 44.69M | 36.02M |
| Total Equity | 94.44M | 96.74M | 73.54M | 68.5M | 51.25M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 539.77M | 495.94M | 348.53M | 170.95M | 113.2M |
| Total Liabilities | 78.63M | 96.27M | 126.17M | 53.6M | 44.69M |
| Total Equity | 461.14M | 399.67M | 222.36M | 117.35M | 68.5M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -28.76M | -56.97M | -84.41M | -104.08M | -26.87M |
| Investing | 45.38M | 55.35M | 69.43M | 104.07M | -52k |
| Financing | -11.36M | 21.67M | 22.33M | 51.48M | 1.03M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -177.98M | -215.71M | -216.22M | -124.37M | -104.08M |
| Investing | -58.8M | -175.34M | 109.59M | 87.36M | 104.07M |
| Financing | 465.28M | 211.5M | 81.84M | 5M | 51.48M |
| Market Cap | 49.69M |
| Price to Earnings Ratio | -0.46 |
| Price to Sales Ratio | 228.81 |
| Price to Cash Ratio | 0.75 |
| Price to Book Ratio | 0.72 |
| Dividend Yield | - |
| Shares Outstanding | 36.67M |
| Average Volume (1 week) | 8.3M |
| Average Volume (1 Month) | 2.61M |
| 52 Week Change | -84.91% |
| 52 Week High | 12.33 |
| 52 Week Low | 1.30 |
| Spread (Intraday) | 0.01 (0.74%) |
| Company Name | Inovio Pharmaceuticals Inc New |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.inovio.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
